{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:59:34Z","timestamp":1769759974452,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,19]]},"DOI":"10.7759\/cureus.69691","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T07:33:29Z","timestamp":1726731209000},"source":"Crossref","is-referenced-by-count":2,"title":["Cutaneous Basal Cell Carcinoma In Situ: A Review of the World Literature"],"prefix":"10.7759","author":[{"given":"Philip R","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10982","article-title":"Basal cell carcinoma: comprehensive clinical and histopathological aspects, novel imaging tools and therapeutic approaches (review)","volume":"23","author":"Niculet E","year":"2022","unstructured":"Niculet E, Craescu M, Rebegea L, et al.. Basal cell carcinoma: comprehensive clinical and histopathological aspects, novel imaging tools and therapeutic approaches (review). Exp Ther Med. 2022, 23:60. 10.3892\/etm.2021.10982","journal-title":"Exp Ther Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15501","article-title":"Basal cell carcinoma: an updated review of pathogenesis and treatment options","volume":"35","author":"Hernandez LE","year":"2022","unstructured":"Hernandez LE, Mohsin N, Levin N, Dreyfuss I, Frech F, Nouri K. Basal cell carcinoma: an updated review of pathogenesis and treatment options. Dermatol Ther. 2022, 35:e15501. 10.1111\/dth.15501","journal-title":"Dermatol Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-022-00201-8","article-title":"Basal cell carcinoma: a narrative review on contemporary diagnosis and management","volume":"10","author":"Naik PP","year":"2022","unstructured":"Naik PP, Desai MB. Basal cell carcinoma: a narrative review on contemporary diagnosis and management. Oncol Ther. 2022, 10:317-35. 10.1007\/s40487-022-00201-8","journal-title":"Oncol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153720","article-title":"Advances in management and therapeutics of cutaneous basal cell carcinoma","volume":"14","author":"Chen OM","year":"2022","unstructured":"Chen OM, Kim K, Steele C, et al.. Advances in management and therapeutics of cutaneous basal cell carcinoma. Cancers (Basel). 2022, 14:14-6. 10.3390\/cancers14153720","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2022.07.005","article-title":"Basal cell carcinoma","volume":"41","author":"Heath MS","year":"2023","unstructured":"Heath MS, Bar A. Basal cell carcinoma. Dermatol Clin. 2023, 41:13-21. 10.1016\/j.det.2022.07.005","journal-title":"Dermatol Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113254","article-title":"European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023","volume":"192","author":"Peris K","year":"2023","unstructured":"Peris K, Fargnoli MC, Kaufmann R, et al.. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023. Eur J Cancer. 2023, 192:113254. 10.1016\/j.ejca.2023.113254","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.060","article-title":"Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations","volume":"80","author":"Cameron MC","year":"2019","unstructured":"Cameron MC, Lee E, Hibler BP, et al.. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019, 80:303-17. 10.1016\/j.jaad.2018.03.060","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0123-8","article-title":"Fibroepithelioma of Pinkus revisited","volume":"6","author":"Haddock ES","year":"2016","unstructured":"Haddock ES, Cohen PR. Fibroepithelioma of Pinkus revisited. Dermatol Ther (Heidelb). 2016, 6:347-62. 10.1007\/s13555-016-0123-8","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref9","article-title":"Melanoma--clinical, dermatoscopical, and histopathological morphological characteristics","volume":"22","author":"Situm M","year":"2014","unstructured":"Situm M, Buljan M, Koli\u0107 M, Vu\u010di\u0107 M. Melanoma--clinical, dermatoscopical, and histopathological morphological characteristics. Acta Dermatovenerol Croat. 2014, 22:1-12.","journal-title":"Acta Dermatovenerol Croat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.057","article-title":"Melanoma in situ: part II. Histopathology, treatment, and clinical management","volume":"73","author":"Higgins HW 2nd","year":"2015","unstructured":"Higgins HW 2nd, Lee KC, Galan A, Leffell DJ. Melanoma in situ: part II. Histopathology, treatment, and clinical management. J Am Acad Dermatol. 2015, 73:193-203. 10.1016\/j.jaad.2015.03.057","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2206348","article-title":"Squamous cell carcinoma of the skin","volume":"388","author":"Wysong A","year":"2023","unstructured":"Wysong A. Squamous cell carcinoma of the skin. N Engl J Med. 2023, 388:2262-73. 10.1056\/NEJMra2206348","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15950","article-title":"Histological classification of cutaneous squamous cell carcinomas with different severity","volume":"33","author":"Schmitz L","year":"2019","unstructured":"Schmitz L, Kanitakis J. Histological classification of cutaneous squamous cell carcinomas with different severity. J Eur Acad Dermatol Venereol. 2019, 33:11-5. 10.1111\/jdv.15950","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020171","article-title":"Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches","volume":"9","author":"Fania L","year":"2021","unstructured":"Fania L, Didona D, Di Pietro FR, et al.. Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches. Biomedicines. 2021, 9:14-6. 10.3390\/biomedicines9020171","journal-title":"Biomedicines"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8032","article-title":"Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics","volume":"7","author":"Cohen PR","year":"2016","unstructured":"Cohen PR, Tomson BN, Elkin SK, Marchlik E, Carter JL, Kurzrock R. Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics. Oncotarget. 2016, 7:23454-67. 10.18632\/oncotarget.8032","journal-title":"Oncotarget"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12966","article-title":"Intraepidermal Merkel cell carcinoma: a case series of a rare entity with clinical follow up","volume":"44","author":"Jour G","year":"2017","unstructured":"Jour G, Aung PP, Rozas-Mu\u00f1oz E, Curry JL, Prieto V, Ivan D. Intraepidermal Merkel cell carcinoma: a case series of a rare entity with clinical follow up. J Cutan Pathol. 2017, 44:684-91. 10.1111\/cup.12966","journal-title":"J Cutan Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29479","article-title":"Cutaneous basal cell carcinoma in situ: a case series","volume":"14","author":"Cohen PR","year":"2022","unstructured":"Cohen PR. Cutaneous basal cell carcinoma in situ: a case series. Cureus. 2022, 14:e29479. 10.7759\/cureus.29479","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5070\/D330163285","article-title":"Basal cell carcinoma in situ of the skin revisited: case reports of the superficial type and fibroepithelioma type of this in situ cutaneous neoplasm","volume":"30","author":"Cohen PR","year":"2024","unstructured":"Cohen PR. Basal cell carcinoma in situ of the skin revisited: case reports of the superficial type and fibroepithelioma type of this in situ cutaneous neoplasm. Dermatol Online J. 2024, 30:14-5. 10.5070\/D330163285","journal-title":"Dermatol Online J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01151-x","article-title":"Cutaneous superficial basal cell is a basal cell carcinoma in situ: electron microscopy of a case series of basal cell carcinomas","volume":"14","author":"Kaur H","year":"2024","unstructured":"Kaur H, de Mesy Bentley KL, Rahman SM, Cohen PR, Smoller BR. Cutaneous superficial basal cell is a basal cell carcinoma in situ: electron microscopy of a case series of basal cell carcinomas. Dermatol Ther (Heidelb). 2024, 14:1359-66. 10.1007\/s13555-024-01151-x","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref19","article-title":"Superficial basal cell carcinoma of the skin is a cutaneous basal cell carcinoma in situ","volume":"22","author":"Cohen PR","year":"2024","unstructured":"Cohen PR. Superficial basal cell carcinoma of the skin is a cutaneous basal cell carcinoma in situ. Skinmed. 2024, 22:165-7.","journal-title":"Skinmed"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081663","article-title":"Appearance of new cutaneous superficial basal cell carcinomas during successful nivolumab treatment of refractory metastatic disease: implications for immunotherapy in early versus late disease","volume":"18","author":"Cohen PR","year":"2017","unstructured":"Cohen PR, Kato S, Goodman AM, Ikeda S, Kurzrock R. Appearance of new cutaneous superficial basal cell carcinomas during successful nivolumab treatment of refractory metastatic disease: implications for immunotherapy in early versus late disease. Int J Mol Sci. 2017, 18:26-8. 10.3390\/ijms18081663","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/npjgenmed.2016.37","article-title":"Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy","volume":"1","author":"Ikeda S","year":"2016","unstructured":"Ikeda S, Goodman AM, Cohen PR, et al.. Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy. NPJ Genom Med. 2016, 1:16037. 10.1038\/npjgenmed.2016.37","journal-title":"NPJ Genom Med"},{"key":"ref22","unstructured":"National Cancer Institute\u2019s Dictionary of Cancer Terms. carcinoma in situ August 28. (2014). Accessed: August 28, 2024: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/carcinoma-in-situ."},{"key":"ref23","unstructured":"National Cancer Institute\u2019s Dictionary of Cancer Terms. invasive cancer. (2014). Accessed: August 28, 2024: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/invasive-cancer."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1946.01510330003001","article-title":"Epithelioma; report on 1,742 treated patients","volume":"53","author":"Elliott JA","year":"1946","unstructured":"Elliott JA, Welton DG. Epithelioma; report on 1,742 treated patients. Arch Derm Syphilol. 1946, 53:307-32. 10.1001\/archderm.1946.01510330003001","journal-title":"Arch Derm Syphilol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1949.01530020145018","article-title":"Epithelioma; clinical and histologic data on 1,025 lesions","volume":"60","author":"Welton DG","year":"1949","unstructured":"Welton DG, Elliot JA, Kimmelstiel P. Epithelioma; clinical and histologic data on 1,025 lesions. Arch Derm Syphilol. 1949, 60:277-93. 10.1001\/archderm.1949.01530020145018","journal-title":"Arch Derm Syphilol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1949.01520260049007","article-title":"Intraepidermal basal cell epithelioma","volume":"59","author":"Sims CF","year":"1949","unstructured":"Sims CF, Parker RL. Intraepidermal basal cell epithelioma. Arch Derm Syphilol. 1949, 59:45-9. 10.1001\/archderm.1949.01520260049007","journal-title":"Arch Derm Syphilol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196405)17:5<609::aid-cncr2820170510>3.0.co;2-l","article-title":"Intraepidermal epithelioma: a critical study","volume":"17","author":"Mehregan AH","year":"1964","unstructured":"Mehregan AH, Pinkus H. Intraepidermal epithelioma: a critical study. Cancer. 1964, 17:609-36. 10.1002\/1097-0142(196405)17:5&lt;609::aid-cncr2820170510&gt;3.0.co;2-l","journal-title":"Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1955.03730310031006","article-title":"The histogenesis of superficial basal-cell epitheliomas; unicentric or multicentric origin","volume":"72","author":"Madsen A","year":"1955","unstructured":"Madsen A. The histogenesis of superficial basal-cell epitheliomas; unicentric or multicentric origin. AMA Arch Derm. 1955, 72:29-30. 10.1001\/archderm.1955.03730310031006","journal-title":"AMA Arch Derm"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1965.01600070044004","article-title":"Basal cell epithelioma. A controlled study of associated factors","volume":"91","author":"Gellin GA","year":"1965","unstructured":"Gellin GA, Kopf AW, Garfinkel L. Basal cell epithelioma. A controlled study of associated factors. Arch Dermatol. 1965, 91:38-45. 10.1001\/archderm.1965.01600070044004","journal-title":"Arch Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32110.x","article-title":"Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer","volume":"32","author":"Cohen PR","year":"2006","unstructured":"Cohen PR, Schulze KE, Nelson BR. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg. 2006, 32:542-51. 10.1111\/j.1524-4725.2006.32110.x","journal-title":"Dermatol Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.5383","article-title":"Characteristics of superficial basal cell carcinomas containing more aggressive subtypes on final histopathological diagnosis","volume":"20","author":"Sohn GK","year":"2021","unstructured":"Sohn GK, Keniston K, Kannan S, Hinds B, Jiang SI. Characteristics of superficial basal cell carcinomas containing more aggressive subtypes on final histopathological diagnosis. J Drugs Dermatol. 2021, 20:283-8. 10.36849\/JDD.5383","journal-title":"J Drugs Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000002954","article-title":"Misclassification of aggressive basal cell carcinoma subtypes and implications for management","volume":"47","author":"Moon D","year":"2021","unstructured":"Moon D, Randall G, Higgins S, Sutton AV, Wysong A. Misclassification of aggressive basal cell carcinoma subtypes and implications for management. Dermatol Surg. 2021, 47:593-8. 10.1097\/DSS.0000000000002954","journal-title":"Dermatol Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000002162","article-title":"Superficial basal cell cancers demonstrate higher rates of mixed histology on high-risk anatomical sites","volume":"46","author":"Petersen ET","year":"2020","unstructured":"Petersen ET, Ahmed SR, Pradhan D, MacFarlane DF. Superficial basal cell cancers demonstrate higher rates of mixed histology on high-risk anatomical sites. Dermatol Surg. 2020, 46:747-51. 10.1097\/DSS.0000000000002162","journal-title":"Dermatol Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12260190","article-title":"Discontinuity of the basement membrane in fibrosing basocellular carcinomas and basosquamous carcinomas of the skin: an immunohistochemical study with human laminin and type IV collagen antibodies","volume":"82","author":"Kallioinen M","year":"1984","unstructured":"Kallioinen M, Autio-Harmainen H, Dammert K, Risteli J, Risteli L. Discontinuity of the basement membrane in fibrosing basocellular carcinomas and basosquamous carcinomas of the skin: an immunohistochemical study with human laminin and type IV collagen antibodies. J Invest Dermatol. 1984, 82:248-51. 10.1111\/1523-1747.ep12260190","journal-title":"J Invest Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12466209","article-title":"Desmoplastic basal cell carcinomas possess unique basement membrane-degrading properties","volume":"88","author":"Barsky SH","year":"1987","unstructured":"Barsky SH, Grossman DA, Bhuta S. Desmoplastic basal cell carcinomas possess unique basement membrane-degrading properties. J Invest Dermatol. 1987, 88:324-9. 10.1111\/1523-1747.ep12466209","journal-title":"J Invest Dermatol"},{"key":"ref36","article-title":"The ultrastructure of aggressive\u2014versus indolent\u2014growth basal cell carcinoma: a comparison study","volume":"78","author":"Hayakawa TJ","year":"1998","unstructured":"Hayakawa TJ, Pilavdzic D, Magro CM, Stane M, Crowson AN. The ultrastructure of aggressive\u2014versus indolent\u2014growth basal cell carcinoma: a comparison study. Lab Invest. 1998, 78:50.","journal-title":"Lab Invest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800512","article-title":"Basal cell carcinoma: biology, morphology and clinical implications","volume":"19","author":"Crowson AN","year":"2006","unstructured":"Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol. 2006, 19:S127-47. 10.1038\/modpathol.3800512","journal-title":"Mod Pathol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104316","article-title":"Cancer predisposition and germline CTNNA1 variants","volume":"64","author":"Lobo S","year":"2021","unstructured":"Lobo S, Benusiglio PR, Coulet F, et al.. Cancer predisposition and germline CTNNA1 variants. Eur J Med Genet. 2021, 64:104316. 10.1016\/j.ejmg.2021.104316","journal-title":"Eur J Med Genet"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0056","article-title":"Basal cell skin cancer, version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Schmults CD","year":"2023","unstructured":"Schmults CD, Blitzblau R, Aasi SZ, et al.. Basal cell skin cancer, version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023, 21:1181-203. 10.6004\/jnccn.2023.0056","journal-title":"J Natl Compr Canc Netw"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.083","article-title":"Basal cell carcinoma: contemporary approaches to diagnosis, treatment, and prevention","volume":"80","author":"Cameron MC","year":"2019","unstructured":"Cameron MC, Lee E, Hibler BP, et al.. Basal cell carcinoma: contemporary approaches to diagnosis, treatment, and prevention. J Am Acad Dermatol. 2019, 80:321-39. 10.1016\/j.jaad.2018.02.083","journal-title":"J Am Acad Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.9655","article-title":"Potential overdiagnosis of basal cell carcinoma in older patients with limited life expectancy","volume":"312","author":"Linos E","year":"2014","unstructured":"Linos E, Schroeder SA, Chren MM. Potential overdiagnosis of basal cell carcinoma in older patients with limited life expectancy. JAMA. 2014, 312:997-8. 10.1001\/jama.2014.9655","journal-title":"JAMA"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2023.101475","article-title":"The therapeutic dilemma of basal cell carcinoma in older adults: a review of the current literature","volume":"14","author":"Van Coile L","year":"2023","unstructured":"Van Coile L, Verhaeghe E, Ongenae K, Destrooper L, Mohamadi Z, Brochez L, Hoorens I. The therapeutic dilemma of basal cell carcinoma in older adults: a review of the current literature. J Geriatr Oncol. 2023, 14:101475. 10.1016\/j.jgo.2023.101475","journal-title":"J Geriatr Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.3020","article-title":"Evaluation of watchful waiting and tumor behavior in patients with basal cell carcinoma: an observational cohort study of 280 basal cell carcinomas in 89 patients","volume":"157","author":"van Winden ME","year":"2021","unstructured":"van Winden ME, Hetterschijt CR, Bronkhorst EM, van de Kerkhof PC, de Jong EM, Lubeek SF. Evaluation of watchful waiting and tumor behavior in patients with basal cell carcinoma: an observational cohort study of 280 basal cell carcinomas in 89 patients. JAMA Dermatol. 2021, 157:1174-81. 10.1001\/jamadermatol.2021.3020","journal-title":"JAMA Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.2643","article-title":"Active surveillance as a management option for low-risk basal cell carcinoma","volume":"181","author":"Linos E","year":"2021","unstructured":"Linos E, Chren MM. Active surveillance as a management option for low-risk basal cell carcinoma. JAMA Intern Med. 2021, 181:1032-3. 10.1001\/jamainternmed.2021.2643","journal-title":"JAMA Intern Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21675","article-title":"US academic dermatologists' attitudes towards active surveillance for basal cell carcinoma","volume":"187","author":"Han J","year":"2022","unstructured":"Han J, O'Neal S, Gravely A, Linos E, Goldfarb N. US academic dermatologists' attitudes towards active surveillance for basal cell carcinoma. Br J Dermatol. 2022, 187:613-5. 10.1111\/bjd.21675","journal-title":"Br J Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac002","article-title":"The perspectives of 606 US dermatologists on active surveillance for low-risk basal cell carcinoma","volume":"188","author":"van Egmond S","year":"2023","unstructured":"van Egmond S, de Vere Hunt I, Cai ZR, et al.. The perspectives of 606 US dermatologists on active surveillance for low-risk basal cell carcinoma. Br J Dermatol. 2023, 188:136-7. 10.1093\/bjd\/ljac002","journal-title":"Br J Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_1276_20","article-title":"The use of dermoscopy in distinguishing the histopathological subtypes of basal cell carcinoma: a retrospective, morphological study","volume":"88","author":"Popadi\u0107 M","year":"2022","unstructured":"Popadi\u0107 M, Brasanac D. The use of dermoscopy in distinguishing the histopathological subtypes of basal cell carcinoma: a retrospective, morphological study. Indian J Dermatol Venereol Leprol. 2022, 88:598-607. 10.25259\/IJDVL_1276_20","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1301a4","article-title":"Clinical, dermoscopic and histopathological evaluation of basal cell carcinoma","volume":"13","author":"G\u00fcrsel \u00dcr\u00fcn Y","year":"2023","unstructured":"G\u00fcrsel \u00dcr\u00fcn Y, Fi\u00e7icio\u011flu S, \u00dcr\u00fcn M, Can N. Clinical, dermoscopic and histopathological evaluation of basal cell carcinoma. Dermatol Pract Concept. 2023, 13:14-6. 10.5826\/dpc.1301a4","journal-title":"Dermatol Pract Concept"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/295880-cutaneous-basal-cell-carcinoma-in-situ-a-review-of-the-world-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T07:33:36Z","timestamp":1726731216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/295880-cutaneous-basal-cell-carcinoma-in-situ-a-review-of-the-world-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.69691","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}